Literature DB >> 18815841

Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.

Elizabeth A Mittendorf1, Aysegul A Sahin, Susan L Tucker, Funda Meric-Bernstam, Min Yi, Khazi M Nayeemuddin, Gildy V Babiera, Merrick I Ross, Barry W Feig, Henry M Kuerer, Kelly K Hunt.   

Abstract

BACKGROUND: Isolated tumor cells (ITC) are more likely to be identified when serial sectioning and immunohistochemical staining are used to evaluate sentinel lymph nodes (SLN). Our goal was to identify clinicopathologic features associated with ITC in patients undergoing sentinel lymph node dissection (SLND).
METHODS: We reviewed clinicopathologic data for 3557 patients with no clinical evidence of lymph node metastases undergoing SLND between November 1993 and March 2007. Patients were staged according to the 6th edition of the American Joint Committee on Cancer staging system, with metastasis <or=.2 mm classified as ITC.
RESULTS: A SLN was identified in 3475 patients (97.7%), including 2518 (72.4%) with negative nodes and 169 (4.9%) with ITC. A statistically significant association existed between lobular histology and the identification of ITC; 13.6% of patients with ITC had lobular histology versus 7.3% of patients with a negative SLN (P = .003). The presence of lymphovascular invasion (LVI) was also associated with ITC; 18.3% of patients with ITC had LVI in the primary tumor versus 8.5% of patients with a negative SLN (P < .001). No difference existed between patients with and without ITC with respect to T stage, grade, estrogen receptor, progesterone receptor, HER2/neu status, or biopsy method.
CONCLUSION: The association between ITC and LVI, a known predictor of poor outcome, suggests ITC may have clinical relevance. The relationship between lobular histology and ITC is consistent with the known pattern of lobular metastases, which frequently present as small foci requiring immunohistochemistry for detection. Longer follow-up is needed to determine whether ITC have prognostic significance.

Entities:  

Mesh:

Year:  2008        PMID: 18815841      PMCID: PMC4331098          DOI: 10.1245/s10434-008-0153-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  36 in total

1.  Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.

Authors:  Aeisha K Rivers; Kent A Griffith; Kelly K Hunt; Amy C Degnim; Michael S Sabel; Kathleen M Diehl; Vincent M Cimmino; Alfred E Chang; Peter C Lucas; Lisa A Newman
Journal:  Ann Surg Oncol       Date:  2006-01-01       Impact factor: 5.344

2.  Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma.

Authors:  Ira J Bleiweiss; Chandandeep S Nagi; Shabnam Jaffer
Journal:  J Clin Oncol       Date:  2006-04-10       Impact factor: 44.544

3.  Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.

Authors:  Judy C Boughey; Isabelle Bedrosian; Funda Meric-Bernstam; Merrick I Ross; Henry M Kuerer; Jeri S Akins; Sharon H Giordano; Gildy V Babiera; Frederick C Ames; Kelly K Hunt
Journal:  J Am Coll Surg       Date:  2006-08-23       Impact factor: 6.113

4.  Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a,bNOMO): clinicopathologic features and outcome.

Authors:  A K Lee; M Loda; G Mackarem; S Bosari; R A DeLellis; G J Heatley; K Hughes
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

5.  Recommendations for sentinel lymph node processing in breast cancer.

Authors:  M A Yared; L P Middleton; T L Smith; H W Kim; M I Ross; K K Hunt; A A Sahin
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

6.  Benign mechanical transport of breast epithelial cells to sentinel lymph nodes.

Authors:  Nils M Diaz; Charles E Cox; Mark Ebert; John D Clark; Vesna Vrcel; Nicholas Stowell; Anu Sharma; James W Jakub; Alan Cantor; Barbara A Centeno; Elisabeth Dupont; Carlos Muro-Cacho; Santo Nicosia
Journal:  Am J Surg Pathol       Date:  2004-12       Impact factor: 6.394

7.  Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.

Authors:  Charles Cox; Laura White; Nathon Allred; Michael Meyers; Daniel Dickson; Elisabeth Dupont; Alan Cantor; Quan Ly; Sophie Dessureault; Jeff King; Santo Nicosia; Vesna Vrcel; Nils Diaz
Journal:  Ann Surg Oncol       Date:  2006-03-16       Impact factor: 5.344

8.  Occult axillary lymph node metastases in "node-negative" breast carcinoma.

Authors:  I A Nasser; A K Lee; S Bosari; R Saganich; G Heatley; M L Silverman
Journal:  Hum Pathol       Date:  1993-09       Impact factor: 3.466

9.  The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma.

Authors:  G Cserni; S Bianchi; V Vezzosi; H Peterse; A Sapino; R Arisio; A Reiner-Concin; P Regitnig; J-P Bellocq; C Marin; R Bori; J M Penuela; A Córdoba Iturriagagoitia
Journal:  J Clin Pathol       Date:  2006-02-23       Impact factor: 3.411

10.  Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.

Authors:  José Luiz B Bevilacqua; Michael W Kattan; Jane V Fey; Hiram S Cody; Patrick I Borgen; Kimberly J Van Zee
Journal:  J Clin Oncol       Date:  2007-07-30       Impact factor: 44.544

View more
  14 in total

1.  Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.

Authors:  Elizabeth A Mittendorf; Kelly K Hunt; Judy C Boughey; Roland Bassett; Amy C Degnim; Robyn Harrell; Min Yi; Funda Meric-Bernstam; Merrick I Ross; Gildy V Babiera; Henry M Kuerer; Rosa F Hwang
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

2.  Clinical and Pathological Factors Affecting the Sentinel Lymph Node Metastasis in Patients with Breast Cancer.

Authors:  Önder Karahallı; Turan Acar; Murat Kemal Atahan; Nihan Acar; Mehmet Hacıyanlı; Kemal Erdinç Kamer
Journal:  Indian J Surg       Date:  2016-05-04       Impact factor: 0.656

Review 3.  Consensus on the regional lymph nodes irradiation in breast cancer.

Authors:  E Bayo; I Herruzo; M Arenas; M Algara
Journal:  Clin Transl Oncol       Date:  2013-03-22       Impact factor: 3.405

4.  Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers.

Authors:  Anita Mamtani; Emily C Zabor; Michelle Stempel; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2019-07-24       Impact factor: 5.344

5.  Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial.

Authors:  Abigail S Caudle; Kelly K Hunt; Henry M Kuerer; Funda Meric-Bernstam; Anthony Lucci; Isabelle Bedrosian; Gildy V Babiera; Rosa F Hwang; Merrick I Ross; Barry W Feig; Karen Hoffman; Jennifer K Litton; Aysegul A Sahin; Wei Yang; Gabriel N Hortobagyi; Thomas A Buchholz; Elizabeth A Mittendorf
Journal:  Ann Surg Oncol       Date:  2011-09       Impact factor: 5.344

6.  Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.

Authors:  Elizabeth A Mittendorf; Karla V Ballman; Linda M McCall; Min Yi; Aysegul A Sahin; Isabelle Bedrosian; Nora Hansen; Sheryl Gabram; Thelma Hurd; Armando E Giuliano; Kelly K Hunt
Journal:  J Clin Oncol       Date:  2014-12-08       Impact factor: 44.544

7.  American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.

Authors:  Abigail S Caudle; Kelly K Hunt; Susan L Tucker; Karen Hoffman; Sarah M Gainer; Anthony Lucci; Henry M Kuerer; Funda Meric-Bernstam; Ruchita Shah; Gildy V Babiera; Aysegul A Sahin; Elizabeth A Mittendorf
Journal:  Ann Surg Oncol       Date:  2012-07-31       Impact factor: 5.344

8.  Which patients need an axillary clearance after sentinel node biopsy?

Authors:  Anastasia Pazaiti; Ian S Fentiman
Journal:  Int J Breast Cancer       Date:  2011-08-24

9.  Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor.

Authors:  Jia-Long Wu; Hsin-Shun Tseng; Li-Heng Yang; Hwa-Koon Wu; Shou-Jen Kuo; Shou-Tung Chen; Dar-Ren Chen
Journal:  Med Sci Monit       Date:  2014-04-08

10.  Tumor characteristics of breast cancer in predicting axillary lymph node metastasis.

Authors:  Hsin-Shun Tseng; Li-Sheng Chen; Shou-Jen Kuo; Shou-Tung Chen; Yu-Fen Wang; Dar-Ren Chen
Journal:  Med Sci Monit       Date:  2014-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.